Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03476759
Other study ID # Tanta University
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2018
Est. completion date October 31, 2021

Study information

Verified date November 2021
Source Tanta University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

2groups with peritoneal adhesions after cesarean delivery will be allocated to either laparoscopic tubal adhesiolysis or to IVF/ICSI


Description:

This randomized clinical trial will be conducted at Tanta university hospitals in fertility and MIS units. Two hundred and fifty 2ry infertility patients with confirmed post C.S adhesions will be included in the study and those patients will be divided randomly in two groups: Group A: 125 patients will be undergoing laparoscopic tubal adhesiolysis and\or tuboplasty then a widow of 12 months post operatively is given for natural conception. Group B: 125 patients will undergo IVF-ICSI procedures. The primary outcome measure of the study will be the rate of clinical pregnancy. Inclusion criteria: - patient's age not exceeding 35 years old - confirmed post caesarean section tubal adhesions (by diagnostic laparoscopy report or video CDs) as a solitary cause of their 2ry infertility. Exclusion criteria: - patient's age >35 years - other causes of infertility as male factor contribution, any ovulatory or endocrinological disorder, - diagnosed any degree of endometriosis - patients with history of recurrent pregnancy loss. - couples with prolonged sexual abstinence for any reason Detailed explanation of the aims, procedures, steps and nature of the study for the participants will be done and a written consent will be signed by each patient before inclusion. After allocation laparoscopic tubal adhesions will be dissected and normal anatomy and function will be restored. In the other group IVF/ICSI will be commenced The follow up with both groups will extend to 1year or till pregnancy is aggrieved The outcomes of the study were pregnancy rates and affordability


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date October 31, 2021
Est. primary completion date October 31, 2021
Accepts healthy volunteers No
Gender Female
Age group 20 Years to 35 Years
Eligibility Inclusion Criteria: - age not exceeding 35 years old with confirmed post caesarean section tubal adhesions (by diagnostic laparoscopy report or video CDs) as a solitary cause of their 2ry infertility. Exclusion Criteria: - patient's age >35 years, male factor contribution, any ovulatory or endocrinological disorder, diagnosed any degree of endometriosis and patients with history of recurrent pregnancy loss. Couples with prolonged sexual abstinence for any reason will be excluded from participation in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Tubal adhesiolysis
125 patients will undergo tubal adhesiolysis or tuboplasty
Drug:
IVF/ICSI
125 patients will undergo IVF-ICSI procedures.

Locations

Country Name City State
Egypt Ayman Shehata Dawood Tanta Algharbia

Sponsors (1)

Lead Sponsor Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Other Affordability Costs of each maneuver Within 1year
Primary clinical pregnancy rate The number of pregnant women in both groups After 1year
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04139629 - Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI N/A
Recruiting NCT05419921 - Comparison of the Diagnostic Accuracy of Hysterosalpingo-lidocaine-foam Sonography Versus Hysterosalpingography in Tubal Patency Assessment to the Gold Standard of Laparoscopy and Dye Testing